Obseva Logo highresolution.jpg
ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update
17 mai 2022 07h00 HE | ObsEva SA
-Linzagolix for uterine fibroids: Received confirmation of positive CHMP opinion for marketing authorization application; United States NDA PDUFA date in Q3:22- -Linzagolix for endometriosis:...
Obseva Logo highresolution.jpg
ObsEva Announces First Quarter 2022 Financial Results and Provides Corporate Update
17 mai 2022 01h00 HE | ObsEva SA
-Linzagolix for uterine fibroids: Received confirmation of positive CHMP opinion for marketing authorization application; United States NDA PDUFA date in Q3:22- -Linzagolix for endometriosis:...
CV_Sciences_logo2021.png
CV Sciences, Inc. Reports First Quarter 2022 Financial Results
16 mai 2022 09h00 HE | CV Sciences, Inc.
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
New Logo.png
ScoutCam Reports First Quarter 2022 Financial Results and Provides Corporate Update
16 mai 2022 08h00 HE | ScoutCam Inc.
Gaining traction in the Condition Based Monitoring (CBM) and Predictive Maintenance (PdM) markets with a patented visual sensor solution and new licensing agreement Omer, Israel, May 16, 2022 ...
BLPG Logo - 2015-09-08 - Horizontal_1514928797362.png
Blue Line Protection Group Announces Corporate Update
06 mai 2022 13h45 HE | Blue Line Protection Group, Inc.
Denver, CO, May 06, 2022 (GLOBE NEWSWIRE) -- Blue Line Protection Group, Inc. (OTCQB: BLPG) (“Blue Line” and the “Company”) is pleased to share a corporate update. Annual Shareholder Meeting ...
life.jpg
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2022
03 mai 2022 16h05 HE | LifeVantage Corporation
SALT LAKE CITY, May 03, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) today reported financial results for its third fiscal quarter ended March 31, 2022. The Company also announced...
Golden Triangle.png
Golden Triangle Ventures, Inc. Announces Corporate Update and Details into Its Partnership and Consulting Contract with Lelantos Holdings, Inc.
29 avr. 2022 08h30 HE | Golden Triangle Ventures, Inc.
LAS VEGAS, April 29, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (or “GTV”) announces an update on its partnership and consulting contract with...
Picture1.jpg
ONCOTELIC PROVIDES YE 2021 FINANCIAL RESULTS COMPARED TO YE 2020, PRODUCT DEVELOPMET INITIATIVES AND CORPORATE UPDATE
18 avr. 2022 07h00 HE | Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (“Oncotelic”, “We” or the “Company”) (OTCQB:OTLC) today announced financial results for the full year ended...
CV_Sciences_logo2021.png
CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results
31 mars 2022 16h05 HE | CV Sciences, Inc.
SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol (CBD)...
logo.jpg
Processa Pharmaceuticals Announces Year-End 2021 Results and Provides Corporate Update
30 mars 2022 16h00 HE | Processa Pharmaceuticals, Inc.
Targeting Major Milestones 2022 HANOVER, Md., March 30, 2022 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) ("Processa" or the "Company"), a clinical stage company developing...